<DOC>
	<DOCNO>NCT01491620</DOCNO>
	<brief_summary>This study evaluate safety efficacy Excel V 532 nm KTP laser treatment dyschromia neck and/or chest ( poikiloderma Civatte ) .</brief_summary>
	<brief_title>Study 532 nm KTP Laser Treatment Poikiloderma Civatte</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Telangiectasis</mesh_term>
	<mesh_term>Pigmentation Disorders</mesh_term>
	<mesh_term>Photosensitivity Disorders</mesh_term>
	<criteria>Fitzpatrick Skin Type I III Clinical diagnosis poikiloderma Civatte affect neck and/or chest Willing refrain use topical corticosteroid , retinoids bleach agent treat area Agree undergo procedure treatment poikiloderma Civatte study Willing able read , understand sign Informed Consent Form Willing able adhere treatment followup schedule posttreatment care instruction Any laser treatment neck and/or chest within 12 month Any topical treatment neck and/or chest within 6 month Pregnant and/or breastfeed Infection , dermatitis rash treatment area Suffering significant concurrent illness , Diabetes Mellitus pertinent neurological disorder History seizure disorder due light , fibromyalgia , connective tissue disease , vitiligo , psoriasis , pigmentary disorder , keloid scarring , hypertrophic scar abnormal wound heal History immunosuppression/immune deficiency disorder currently use immunosuppressive medication Having know anticoagulative condition take anticoagulation medication History disease stimulate heat , unless treatment conduct follow prophylactic regimen Having undergone surgery treatment area within 6 month treatment ( skin heal completely ) History radiation head , neck and/or upper chest Undergoing systemic chemotherapy treatment cancer Systemic use isotretinoin ( AccutaneÂ® ) within 6 month Any use gold therapy Excessively tan area treat unable/unlikely refrain tan study Current smoker history smoking within 12 month study Participation study another device drug within 6 month As per Investigator 's discretion , physical mental condition might make unsafe subject participate study</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>poikiloderma Civatte</keyword>
	<keyword>red dyschromia</keyword>
	<keyword>brown dyschromia</keyword>
	<keyword>sun damage</keyword>
	<keyword>neck</keyword>
	<keyword>chest</keyword>
	<keyword>dyschromia</keyword>
	<keyword>pigmentation disorder</keyword>
	<keyword>erythema</keyword>
	<keyword>photosensitivity disorder</keyword>
	<keyword>sun exposure</keyword>
	<keyword>telangiectasia</keyword>
	<keyword>hyperpigmentation</keyword>
	<keyword>hypopigmentation</keyword>
</DOC>